91 related articles for article (PubMed ID: 3690590)
1. [Anti-hypertensive activity of P0285 and nifedipine in conscious normotensive rats and in rats with spontaneous, renal and desoxycorticosterone acetate-induced hypertension].
Marchini F; Luca C; Valli L; Pacei E
Cardiologia; 1987 Jul; 32(7):659-62. PubMed ID: 3690590
[No Abstract] [Full Text] [Related]
2. Antihypertensive effect of KB-944, a new calcium antagonist, in conscious normotensive and hypertensive rats.
Morita T; Kanazawa T; Ito K; Nose T
Arzneimittelforschung; 1982; 32(9):1047-52. PubMed ID: 6890824
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological studies on a new dihydrothienopyridine calcium antagonist. 3rd communication: antihypertensive effects of S-(+)-methyl-4,7-dihydro-3-isobutyl-6-methyl-4-(3-nitrophenyl)thieno[2, 3-b] pyridine-5-carboxylate in hypertensive rats and dogs.
Ueda M; Matsumura S; Masui M; Matsuura E; Kawakami M; Fujitomo H; Umeda T; Kagawa H; Hirohata S; Shima K
Arzneimittelforschung; 1993 Dec; 43(12):1282-90. PubMed ID: 8141815
[TBL] [Abstract][Full Text] [Related]
4. Antihypertensive activity of a new calcium channel blocker LF 2.0254, in spontaneously hypertensive rats: a comparison with nifedipine and nicardipine.
Pruneau D; Brown NL
Arch Int Pharmacodyn Ther; 1988; 295():109-24. PubMed ID: 2977540
[TBL] [Abstract][Full Text] [Related]
5. Antihypertensive effects of a new dihydropyridine calcium antagonist.
Kimura Y; Fukui H; Tanaka M; Okamoto M; Morino A; Miura A; Kimura K; Enomoto H
Arzneimittelforschung; 1986 Sep; 36(9):1329-35. PubMed ID: 3790182
[TBL] [Abstract][Full Text] [Related]
6. [Anti-angina activity of nifedipine and P0285 in the anesthetized rat].
Luca C; Marchini F; Pacei E
Cardiologia; 1987 Jul; 32(7):663-5. PubMed ID: 3319157
[No Abstract] [Full Text] [Related]
7. Antihypertensive effects of lercanidipine in experimental hypertensive rats and dogs.
Sironi G; Montagna E; Greto L; Bianchi G; Leonardi A; Testa R
Arzneimittelforschung; 1996 Feb; 46(2):145-52. PubMed ID: 8720303
[TBL] [Abstract][Full Text] [Related]
8. Regional vascular effects of MPC-1304, a novel dihydropyridine derivative, in conscious normotensive and spontaneously hypertensive rats.
Miyoshi K; Kanda A; Nozawa Y; Nakano M; Miyake H
J Pharmacol Exp Ther; 1996 Jun; 277(3):1328-36. PubMed ID: 8667194
[TBL] [Abstract][Full Text] [Related]
9. Antihypertensive effects of nisoldipine and reference drugs in certain types of hypertensive rats.
Tasaka K; Kamei C; Tagami H; Hokonohara T; Sugimoto Y
Arzneimittelforschung; 1987 Mar; 37(3):316-21. PubMed ID: 3297074
[TBL] [Abstract][Full Text] [Related]
10. [The effect of verapamil on cardio- and hemodynamics in rats with various models of hypertension].
Spasov AA; Gurbanov KG; Seredintseva NV; Paperno AA
Eksp Klin Farmakol; 1997; 60(3):30-3. PubMed ID: 9324394
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological profile of barnidipine: a single optical isomer dihydropyridine calcium antagonist.
van Zwieten PA
Blood Press Suppl; 1998; 1():5-8. PubMed ID: 9660520
[TBL] [Abstract][Full Text] [Related]
12. Acute antihypertensive effects of the new generation calcium antagonist 3-pyridine carboxylic acid 5-[(cyclopropylamino)-carbonyl]-1,4-dihydro-2,6-dimethyl-4-(2-nitrophen yl) octyl ester on conscious spontaneously hypertensive rats and renal hypertensive rats.
Hojo M; Tanaka Y; Katayama O; Teramoto N
Arzneimittelforschung; 1993 Aug; 43(8):847-51. PubMed ID: 8216440
[TBL] [Abstract][Full Text] [Related]
13. A comparative study of morphological changes in spontaneously hypertensive rats and normotensive Wistar Kyoto rats treated with an angiotensin-converting enzyme inhibitor or a calcium-channel blocker.
Saleh FH; Jurjus AR
J Pathol; 2001 Mar; 193(3):415-20. PubMed ID: 11241424
[TBL] [Abstract][Full Text] [Related]
14. Antihypertensive effects of a new transdermal delivery system for clonidine in genetic and experimental hypertensive rats.
Ishii R; Tagawa T; Ishida T; Naruse T
Arzneimittelforschung; 1996 Mar; 46(3):261-8. PubMed ID: 8901146
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin converting enzyme inhibition and dihydropyridine calcium channel blockade in the treatment of left ventricular hypertrophy in arterial hypertension.
Palmieri V; Devereux RB
Minerva Cardioangiol; 2002 Jun; 50(3):169-74. PubMed ID: 12107398
[TBL] [Abstract][Full Text] [Related]
16. Antihypertensive and cardiovascular effects of the new dihydropyridine derivative methyl (E)-3-phenyl-2-propen-1-yl-1,4-dihydro-2,6-dimethyl- 4-(3-nitrophenyl)pyridine-3,5-dicarboxylate.
Yamaura T; Kase N; Kita H; Uematsu T
Arzneimittelforschung; 1986; 36(1):29-34. PubMed ID: 3754142
[TBL] [Abstract][Full Text] [Related]
17. Effects of calcium antagonists in hypertensive patients with renal dysfunction: a prospective, randomized, parallel trial comparing benidipine and nifedipine.
Inoue S; Tomino Y
Nephrology (Carlton); 2004 Oct; 9(5):265-71. PubMed ID: 15504138
[TBL] [Abstract][Full Text] [Related]
18. Antihypertensive effects of long-acting calcium channel blockers on hemodialysis days--a randomized crossover trial between benidipine and nifedipine CR.
Kojima M; Taniguchi M; Sato K; Ueda R; Dohi Y
Nephron Clin Pract; 2004; 97(2):c49-53. PubMed ID: 15218330
[TBL] [Abstract][Full Text] [Related]
19. The T- and L-type calcium channel blocker (CCB) mibefradil attenuates leg edema induced by the L-type CCB nifedipine in the spontaneously hypertensive rat: a novel differentiating assay.
Major TC; Dhamija S; Black N; Liachenko S; Morenko B; Sobocinski G; Okerberg C; Tinholt P; Madore S; Kowala MC
J Pharmacol Exp Ther; 2008 Jun; 325(3):723-31. PubMed ID: 18326812
[TBL] [Abstract][Full Text] [Related]
20. Renal effects of calcium antagonists with special reference to manidipine hydrochloride.
Rodicio JL
Blood Press Suppl; 1996; 5():10-5. PubMed ID: 8973787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
